Blood Bank Product Receives Market Approval From Food And Drug Administration

Main Category: Blood / Hematology
Also Included In: Medical Devices / Diagnostics
Article Date: 29 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


SCC Soft Computer's blood bank product, SoftBank® II, version 23.2 received market approval from the Food and Drug Administration (FDA) on August 12, 2008.

SoftBank II version 23.2 was designed to have the added capability to print ISBT-compliant labels for modified blood products. The functionality of the predicate device, SoftBank II version 23.1 with Database Management System Interface, is the foundation on which the added functionality of ISBT-complaint label printing was designed.

"As decision support software devices that are highly regulated and require knowledgeable user intervention to document certain steps and events in a transfusion service environment, it is important that our blood services products keep pace with industry standards, such as the usage of ISBT labels," said Gilbert Hakim, CEO, SCC Soft Computer. "I am confident that SoftBank will remain on the leading edge in this competitive market."

SoftBank II is a centralized transfusion service management system that combines previous high-performance functionality with exciting new features to provide a comprehensive, cost-effective centralized testing solution. The database management system offers, fast, direct linking between records and transactions. This dramatically increases levels of security and integrity when performing and documenting activities and events. As a major asset to the laboratory, SoftBank II provides critical safety functions throughout the system allowing the laboratory's focus to remain on providing safe blood products to patients.

For nearly 30 years, SCC Soft Computer has been meeting the needs of the healthcare industry by providing powerful, clinical information solutions to hospitals, large IDNs (integrated delivery networks), and laboratories. Healthcare organizations seeking expertise, innovation, and a commitment to quality in healthcare information technology turn to SCC Soft Computer for best of breed clinical software applications. SCC offers full suites of Web-enabled clinical information management software. For more information, contact Ellie Vahman at ellie@softcomputer.com or (727) 789-0100 ext. 4052.

http://www.softcomputer.com

Article adapted by Medical News Today from original press release.
Visit our blood / hematology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
SCC Soft Computer. "Blood Bank Product Receives Market Approval From Food And Drug Administration." Medical News Today. MediLexicon, Intl., 29 Aug. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/119552.php>

APA
SCC Soft Computer. (2008, August 29). "Blood Bank Product Receives Market Approval From Food And Drug Administration." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/119552.php.

Please note: If no author information is provided, the source is cited instead.


Blood / Hematology

What is Hemophilia?

Hemophilia is a group of inherited blood disorders in which the blood does not clot properly. Bleeding disorders are due to defects in the blood vessels, the coagulation mechanism, or the blood platelets. Read more...

Most Popular Articles



Follow Our Blood News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Blood / Hematology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »